Cat. No. |
Product Name |
Information |
PC-62959 |
AR-HO47108
|
AR-HO47108 is a potent, selective acid pump antagonist (potassium-competitive acid blocker or P-CAB) that reversiblely inhibits gastric H+/K+-ATPase with pIC50 of 7.0. |
PC-62893 |
CS-526
|
CS-526 (AKU 517. |
PC-62892 |
Revaprazan
|
Revaprazan (SB-641257. |
PC-62891 |
Revaprazan hydrochloride
|
Revaprazan (SB-641257. |
PC-62890 |
SCH-28080
|
SCH-28080 is a potent, orally active, reversible inhibitor of gastric H+,K+-ATPase with IC50 of 20 nM. |
PC-62889 |
PF-03716556
|
PF-03716556 is a potent, selective, competitive and reversible gastric H+,K+-ATPase with pIC50 of 7.0 in porcine ion-tight membrane vesicle. |
PC-61362 |
Abeprazan
|
Abeprazan is an acid pump inhibitor.. |
PC-60077 |
Azeloprazole sodium
|
A novel potent, orally active proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM. |
PC-60032 |
Azeloprazole
|
A novel potent proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM. |
PC-45145 |
Esomeprazole agnesium trihydrate
|
A proton pump inhibitor that reduces stomach acid secretion by inhibition of the H+/K+-ATPase in the parietal cells. |
PC-45144 |
Esomeprazole potassium salt
|
A proton pump inhibitor that reduces stomach acid secretion by inhibition of the H+/K+-ATPase in the parietal cells. |
PC-45143 |
Esomeprazole magnesium salt
|
A proton pump inhibitor that reduces stomach acid secretion by inhibition of the H+/K+-ATPase in the parietal cells. |